BioCentury | Nov 3, 2008
Company News

Genelabs, GlaxoSmithKline deal

...consist of small molecule inhibitors of non-structural protein 5A (NS5A) , NS5B , NS4B and HCV replicase...
BioCentury | Oct 31, 2008
Company News

GSK to acquire Genelabs

...non-structural protein 5A , HCV non-structural protein 5B (NS5B) , HCV non-structural protein 4B and HCV replicase...
BioCentury | Sep 27, 2007
Financial News

Genelabs raises $23.7 million

...molecule inhibitors of HCV non-structural protein 5A (NS5A) , HCV non-structural protein 4B (NS4B), and HCV replicase...
BioCentury | Dec 6, 2004
Strategy

Gilead: learning its I, B, Cs

...further upstream by inhibiting the formation of a group of non-structural proteins into a functional HCV replicase...
Items per page:
1 - 4 of 4